Next generation sequencing techonology (RNA-seq) [9], as a new technology with high precision and reliability has been applied in screening various tumor genes, such as LncRNA Transforming Growth Factor β(ATB) in breast cancer [10], lncRNA nuclear-enriched abundant transcript 1(NEAT1) in prostate cancer [11]. This evidence concerns the gene NEAT1 and prostate carcinoma.